- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
GH Research Stock (NASDAQ:GHRS), Quotes and News Summary
GH Research Stock (NASDAQ: GHRS)
| Day Range11.54 - 13.13 | 52 Wk Range8.72 - 24.25 | Open / Close12.5 / 11.62 | Float / Outstanding20.9M / 52M |
| Vol / Avg.15.9K / 43.2K | Mkt Cap604.5M | P/E- | 50d Avg. Price12.97 |
| Div / Yield- | Payout Ratio- | Total Float20.9M | EPS0.01 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-12-05 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | 0.006 | 0.1760 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
GH Research Questions & Answers
You can purchase shares of GH Research (NASDAQ: GHRS) through any online brokerage.
Other companies in GH Research’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Aerie Pharmaceuticals (NASDAQ:AERI) and SNDL (NASDAQ:SNDL).
The latest price target for GH Research (NASDAQ: GHRS) was reported by HC Wainwright & Co. on Tuesday, August 16, 2022. The analyst firm set a price target for 45.00 expecting GHRS to rise to within 12 months (a possible 287.26% upside). 3 analyst firms have reported ratings in the last year.
The stock price for GH Research (NASDAQ: GHRS) is $11.62 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for GH Research.
GH Research’s Q3 earnings are confirmed for Monday, December 5, 2022.
There is no upcoming split for GH Research.
GH Research is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.